A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation

Brachytherapy

Volumn 8, Issue 4, 2009, Pages 373-378

  Wilder, Richard B ^a   Curcio, Lisa D ^a   Khanijou, Rajesh K ^a   Eisner, Martin E ^a   Kakkis, Jane L ^a   Chittenden, Lucy ^a   Agustin, Jeffrey ^a   Lizarde, Jessica ^a   Mesa, Albert V ^a   Ravera, John ^a   Tokita, Kenneth M ^a  

^a Cancer Center of Irvine   (United States)

Author keywords

Accelerated; Breast; Contura; Irradiation; MammoSite; Partial

Indexed keywords

IRIDIUM 192;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; AGED; BRACHYTHERAPY; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT;

EID: 70349431080     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.04.002     Document Type: Article

References (23)

1. Polgar C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-Year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 694-702
2. Sarin R. Partial-breast treatment for early breast cancer: Emergence of a new paradigm. Nat Clin Pract Oncol 2 (2005) 40-47
3. Bensaleh S., Bezak E., and Borg M. Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes. Acta Oncol 48 (2009) 487-494
4. Garza R., Albuquerque K., and Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy 5 (2006) 235-238
5. Stewart A.J., O'Farrell D.A., Cormack R.A., et al. Dose volume histogram analysis of normal structures associated with accelerated intracavitary partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol 3 (2008) 39
6. Evans S.B., Kaufman S.A., Price L.L., et al. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: Incidence, pathologic anatomy, and contributing factors. Int J Radiat Oncol Biol Phys 65 (2006) 333-339
7. Vicini F., Beitsch P.D., Quiet C.A., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112 (2008) 758-766
8. Watkins J.M., Harper J.L., Dragun A.E., et al. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy 7 (2008) 305-309
9. Cuttino L.W., Keisch M., Jenrette J.M., et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-Year results. Int J Radiat Oncol Biol Phys 71 (2008) 107-114
10. Yoshida K., Nose T., Masuda N., et al. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer 16 (2009) 105-112
11. Strauss J.B., and Dickler A. Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. Radiother Oncol 91 (2009) 157-165
12. Wojcicka J.B., Lasher D.E., Malcom R., et al. Clinical and dosimetric experience with MammoSite-based brachytherapy under the RTOG 0413 protocol. J Appl Clin Med Phys 8 (2007) 2654
13. Jeruss J.S., Vicini F.A., Beitsch P.D., et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol 13 (2006) 967-976
14. Vicini F.A., Kestin L.L., and Goldstein N.S. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 60 (2004) 722-730
15. Benitez P.R., Keisch M.E., Vicini F., et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194 (2007) 456-462
16. Cuttino L.W., Todor D., Rosu M., et al. Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity. Brachytherapy 8 (2009) 223-226
17. Dickler A., Seif N., Kirk M.C., et al. A dosimetric comparison of MammoSite((R)) and ClearPath high-dose-rate breast brachytherapy devices. Brachytherapy 8 (2009) 14-18
18. Scanderbeg D.J., Yashar C., Rice R., et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol 90 (2009) 36-42
19. Ott O.J., Hildebrandt G., Potter R., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 82 (2007) 281-286
20. Cassidy L.D. Basic concepts of statistical analysis for surgical research. J Surg Res 128 (2005) 199-206
21. Dwyer A.J. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology 178 (1991) 328-330
22. Gliner J.A., Morgan G.A., and Harmon R.J. Single-factor repeated-measures designs: Analysis and interpretation. J Am Acad Child Adolesc Psychiatry 41 (2002) 1014-1016
23. Wilkinson J.B., Boyle T., Song J., et al. Surgeon-performed ultrasound reliably predicts skin spacing and may decrease the rate of MammoSite balloon catheter explantation in patients undergoing brachytherapy for breast cancer. Am J Surg 196 (2008) 289-292